A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT04946890 · UNKNOWN
Trial details
- NCT number
- NCT04946890
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2024-12-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.